PETMED EXPRESS INC (PETS) Stock Fundamental Analysis
USA - NASDAQ:PETS - US7163821066 - Common Stock
2.58 USD
+0.13 (+5.31%)
2.64 USD
+0.06 (+2.33%)
Taking everything into account, PETS scores 3 out of 10 in our fundamental rating. PETS was compared to 122 industry peers in the Specialty Retail industry. While PETS has a great health rating, there are worries on its profitability. PETS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
PETS had negative earnings in the past year.
PETS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PETS reported negative net income in multiple years.
Of the past 5 years PETS 4 years had a positive operating cash flow.
1.2 Ratios
PETS has a Return On Assets (0.25%) which is comparable to the rest of the industry.
PETS has a Return On Equity (0.37%) which is in line with its industry peers.
The Return On Invested Capital of PETS (1.24%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROIC | 1.24% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PETS's Profit Margin of 0.14% is in line compared to the rest of the industry. PETS outperforms 50.82% of its industry peers.
PETS has a Operating Margin (0.62%) which is in line with its industry peers.
Looking at the Gross Margin, with a value of 27.68%, PETS is doing worse than 68.85% of the companies in the same industry.
PETS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
2. Health
2.1 Basic Checks
PETS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
PETS has an Altman-Z score of 3.34. This indicates that PETS is financially healthy and has little risk of bankruptcy at the moment.
PETS has a Altman-Z score of 3.34. This is in the better half of the industry: PETS outperforms 74.59% of its industry peers.
There is no outstanding debt for PETS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.34 |
ROIC/WACC0.13
WACC9.25%
2.3 Liquidity
PETS has a Current Ratio of 1.43. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PETS (1.43) is comparable to the rest of the industry.
PETS has a Quick Ratio of 1.18. This is a normal value and indicates that PETS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.18, PETS is doing good in the industry, outperforming 79.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
PETS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.00%, which is quite impressive.
EPS 1Y (TTM)22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.13%
3.2 Future
The Earnings Per Share is expected to grow by 42.60% on average over the next years. This is a very strong growth
Based on estimates for the next years, PETS will show a decrease in Revenue. The Revenue will decrease by -3.12% on average per year.
EPS Next Y26.23%
EPS Next 2Y42.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.05%
Revenue Next 2Y-5.92%
Revenue Next 3Y-3.12%
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
PETS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PETS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
99.18% of the companies in the same industry are more expensive than PETS, based on the Enterprise Value to EBITDA ratio.
PETS's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 63.43 | ||
| EV/EBITDA | 0.49 |
4.3 Compensation for Growth
PETS's earnings are expected to grow with 42.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.6%
EPS Next 3YN/A
5. Dividend
5.1 Amount
PETS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
2.58
+0.13 (+5.31%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners38.7%
Inst Owner Change-1.61%
Ins Owners6.24%
Ins Owner Change6.97%
Market Cap54.23M
Revenue(TTM)N/A
Net Income(TTM)357.00K
Analysts40
Price Target2.81 (8.91%)
Short Float %12.11%
Short Ratio16.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.59
Dividend Growth(5Y)-11.13%
DP54.34%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-96.08%
Min EPS beat(2)-488.23%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)-36.55%
Min EPS beat(4)-488.23%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-169.93%
EPS beat(12)4
Avg EPS beat(12)-128.55%
EPS beat(16)4
Avg EPS beat(16)-101.84%
Revenue beat(2)0
Avg Revenue beat(2)-12.18%
Min Revenue beat(2)-12.84%
Max Revenue beat(2)-11.51%
Revenue beat(4)1
Avg Revenue beat(4)-8.81%
Min Revenue beat(4)-12.84%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-6.94%
Revenue beat(12)1
Avg Revenue beat(12)-6.81%
Revenue beat(16)1
Avg Revenue beat(16)-6.96%
PT rev (1m)-8.33%
PT rev (3m)-8.33%
EPS NQ rev (1m)90.82%
EPS NQ rev (3m)25%
EPS NY rev (1m)185.42%
EPS NY rev (3m)356.25%
Revenue NQ rev (1m)5.68%
Revenue NQ rev (3m)5.68%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | 63.43 | ||
| P/OCF | 11.23 | ||
| P/B | 0.56 | ||
| P/tB | 1 | ||
| EV/EBITDA | 0.49 |
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)0.04
FCFY1.58%
OCF(TTM)0.23
OCFY8.91%
SpS11.75
BVpS4.58
TBVpS2.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 0.37% | ||
| ROCE | 1.57% | ||
| ROIC | 1.24% | ||
| ROICexc | 2.57% | ||
| ROICexgc | 23.86% | ||
| OM | 0.62% | ||
| PM (TTM) | 0.14% | ||
| GM | 27.68% | ||
| FCFM | 0.35% |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
F-Score7
Asset Turnover1.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 57.96% | ||
| Cap/Sales | 1.61% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.63% | ||
| Profit Quality | 239.5% | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.34 |
F-Score7
WACC9.25%
ROIC/WACC0.13
Cap/Depr(3y)91.99%
Cap/Depr(5y)95.64%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125.68%
EPS Next Y26.23%
EPS Next 2Y42.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-30.13%
Revenue Next Year-14.05%
Revenue Next 2Y-5.92%
Revenue Next 3Y-3.12%
Revenue Next 5YN/A
EBIT growth 1Y111.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.71%
EBIT Next 3Y42.82%
EBIT Next 5YN/A
FCF growth 1Y-96.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.97%
OCF growth 3Y-52.42%
OCF growth 5Y-37.46%
PETMED EXPRESS INC / PETS FAQ
What is the ChartMill fundamental rating of PETMED EXPRESS INC (PETS) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PETS.
What is the valuation status of PETMED EXPRESS INC (PETS) stock?
ChartMill assigns a valuation rating of 2 / 10 to PETMED EXPRESS INC (PETS). This can be considered as Overvalued.
What is the profitability of PETS stock?
PETMED EXPRESS INC (PETS) has a profitability rating of 2 / 10.
How financially healthy is PETMED EXPRESS INC?
The financial health rating of PETMED EXPRESS INC (PETS) is 7 / 10.
Can you provide the dividend sustainability for PETS stock?
The dividend rating of PETMED EXPRESS INC (PETS) is 0 / 10 and the dividend payout ratio is 54.34%.